Association between aspirin use during pregnancy and cardiovascular risk factors 2-7 years after delivery: The nuMoM2b Heart Health Study.

[1]  Roman Goldenberg,et al.  Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial , 2020, The Lancet.

[2]  Jerry Q. Cheng,et al.  Preeclamptic Women Are at Significantly Higher Risk of Future Cardiovascular Outcomes Over a 15-Year Period. , 2020, Journal of women's health.

[3]  M. Raad,et al.  Usefulness of Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease. , 2019, The American journal of cardiology.

[4]  C. Parker,et al.  Association of Adverse Pregnancy Outcomes With Hypertension 2 to 7 Years Postpartum , 2019, Journal of the American Heart Association.

[5]  G. Gore,et al.  Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications: Systematic Review and Meta-Analysis , 2019, Circulation.

[6]  C. Gyamfi‐Bannerman,et al.  Low‐dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women , 2018, American journal of obstetrics and gynecology.

[7]  S. Cicero,et al.  Prediction and prevention of small‐for‐gestational‐age neonates: evidence from SPREE and ASPRE , 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[8]  Bei Xu,et al.  The effect of acetyl salicylic acid (Aspirin) on trophoblast-endothelial interaction in vitro. , 2017, Journal of reproductive immunology.

[9]  Nicola Persico,et al.  Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia , 2017, The New England journal of medicine.

[10]  S. Leonardi,et al.  Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease , 2017, European journal of preventive cardiology.

[11]  B. Mol,et al.  Antiplatelet Agents and the Prevention of Spontaneous Preterm Birth: A Systematic Review and Meta-analysis. , 2017, Obstetrics and gynecology.

[12]  C. Chew‐Graham,et al.  Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis , 2017, Circulation. Cardiovascular quality and outcomes.

[13]  Dexter Canoy,et al.  Hypertension in pregnancy and risk of coronary heart disease and stroke: A prospective study in a large UK cohort , 2016, International journal of cardiology.

[14]  C. Parker,et al.  Pregnancy as a Window to Future Cardiovascular Health: Design and Implementation of the nuMoM2b Heart Health Study. , 2016, American journal of epidemiology.

[15]  A. Wilcox,et al.  Duration of pregnancy, even at term, predicts long-term risk of coronary heart disease and stroke mortality in women: a population-based study. , 2015, American journal of obstetrics and gynecology.

[16]  C. Patrono.  The Multifaceted Clinical Readouts of Platelet Inhibition by Low-Dose Aspirin. , 2015, Journal of the American College of Cardiology.

[17]  M. LeFevre.  Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. , 2014, Annals of internal medicine.

[18]  W. Callaghan,et al.  History of preterm birth and subsequent cardiovascular disease: a systematic review. , 2014, American journal of obstetrics and gynecology.

[19]  G. Davı̀,et al.  Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.

[20]  M. Schull,et al.  Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study , 2005, The Lancet.

[21]  R. Hermida,et al.  Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. , 1997, Hypertension.

[22]  Jeffrey R. Wilson,et al.  CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.

[23]  A. Raziel,et al.  Prevention of Pregnancy‐Induced Hypertension in Twins by Early Administration of Low‐Dose Aspirin: A Preliminary Report , 1994, American journal of reproductive immunology.

[24]  B. Sibai,et al.  Prevention of preeclampsia with low‐dose aspirin in healthy, nulliparous pregnant women , 1993, The New England journal of medicine.

[25]  G. Cutter,et al.  Low-dose aspirin therapy to prevent preeclampsia. , 1993, American journal of obstetrics and gynecology.

[26]  S. Uzan,et al.  Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial , 1991, The Lancet.

[27]  E. Ruppin,et al.  The use of aspirin to prevent pregnancy‐induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies , 1989, The New England journal of medicine.

[28]  H. Wallenburg,et al.  LOW-DOSE ASPIRIN PREVENTS PREGNANCY-INDUCED HYPERTENSION AND PRE-ECLAMPSIA IN ANGIOTENSIN-SENSITIVE PRIMIGRAVIDAE , 1986, The Lancet.